Craig A. Sponseller

1.2k total citations
33 papers, 750 citations indexed

About

Craig A. Sponseller is a scholar working on Surgery, Emergency Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Craig A. Sponseller has authored 33 papers receiving a total of 750 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Surgery, 10 papers in Emergency Medicine and 8 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Craig A. Sponseller's work include Lipoproteins and Cardiovascular Health (23 papers), HIV-related health complications and treatments (10 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (8 papers). Craig A. Sponseller is often cited by papers focused on Lipoproteins and Cardiovascular Health (23 papers), HIV-related health complications and treatments (10 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (8 papers). Craig A. Sponseller collaborates with scholars based in United States, Japan and France. Craig A. Sponseller's co-authors include Stuart Campbell, Judith A. Aberg, Bruce R. Bacon, Roger Morgan, Jerome D. Cohen, Kevin C. Maki, Terry A. Jacobson, Brent A. Neuschwander‐Tetri, Elizabeth M. Brunt and Kent R. Wehmeier and has published in prestigious journals such as Journal of Clinical Investigation, Gastroenterology and Journal of the American College of Cardiology.

In The Last Decade

Craig A. Sponseller

32 papers receiving 733 citations

Peers

Countries citing papers authored by Craig A. Sponseller

Since Specialization

Citations

This map shows the geographic impact of Craig A. Sponseller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Craig A. Sponseller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Craig A. Sponseller more than expected).

Fields of papers citing papers by Craig A. Sponseller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Craig A. Sponseller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Craig A. Sponseller. The network helps show where Craig A. Sponseller may publish in the future.

Co-authorship network of co-authors of Craig A. Sponseller

This figure shows the co-authorship network connecting the top 25 collaborators of Craig A. Sponseller. A scholar is included among the top collaborators of Craig A. Sponseller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Craig A. Sponseller. Craig A. Sponseller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Statin-dependent and -independent pathways are associated with major adverse cardiovascular events in people with HIV 2025 ·Journal of Clinical Investigation ·Márton Kolossváry, Irini Sereti, Markella V. Zanni, Carl J. Fichtenbaum, Judith A. Aberg, Gerald S. Bloomfield, Carlos Malvestutto, Judith S. Currier, (unknown), Marissa R Diggs, Amy Shirong Lu, Christopher R. deFilippi, Borek Foldyna, Sara McCallum, Craig A. Sponseller, Michael T. Lu, Pamela S. Douglas, Heather J. Ribaudo, Steven Grinspoon	0
2	Rationale and design of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE) 2019 ·American Heart Journal ·Steven Grinspoon, Kathleen V. Fitch, Edgar T. Overton, Carl J. Fichtenbaum, Markella V. Zanni, Judith A. Aberg, Carlos Malvestutto, Michael T. Lu, Judith S. Currier, Craig A. Sponseller, Myron A. Waclawiw, Beverly Alston‐Smith, Katharine Cooper‐Arnold, Karin L. Klingman, Patrice Desvigne‐Nickens, Udo Hoffmann, Heather J. Ribaudo, Pamela S. Douglas	89
3	Assessing statin effects on cardiovascular pathways in HIV using a novel proteomics approach: Analysis of data from INTREPID, a randomized controlled trial 2018 ·EBioMedicine ·Mabel Toribio, Kathleen V. Fitch, Lauren Stone, Markella V. Zanni, Janet Lo, (unknown), Craig A. Sponseller, Hang Lee, Ida Grundberg, Melanie Thompson, Judith A. Aberg, Steven Grinspoon	16
4	Pitavastatin versus pravastatin in adults with HIV-1 infection and dyslipidaemia (INTREPID): 12 week and 52 week results of a phase 4, multicentre, randomised, double-blind, superiority trial 2017 ·The Lancet HIV ·Judith A. Aberg, Craig A. Sponseller, Douglas Ward, (unknown), Stuart Campbell, Melanie Thompson	61
5	Effects of pitavastatin and pravastatin on markers of immune activation and arterial inflammation in HIV 2017 ·AIDS ·Mabel Toribio, Kathleen V. Fitch, (unknown), Tricia H. Burdo, Kenneth C. Williams, Craig A. Sponseller, (unknown), Judith A. Aberg, Markella V. Zanni, Steven Grinspoon	68
6	Gender differences in side effects and attitudes regarding statin use in the Understanding Statin Use in America and Gaps in Patient Education (USAGE) study 2016 ·Journal of clinical lipidology ·Dean G. Karalis, Robert A. Wild, Kevin C. Maki, (unknown), Terry A. Jacobson, Craig A. Sponseller, Jerome D. Cohen	114
7	Metabolic syndrome is associated with muscle symptoms among statin users 2016 ·Journal of clinical lipidology ·Eliot A. Brinton, Kevin C. Maki, Terry A. Jacobson, Craig A. Sponseller, Jerome D. Cohen	11
8	Pitavastatin 4 mg Provides Significantly Greater Reduction in Remnant Lipoprotein Cholesterol Compared With Pravastatin 40 mg: Results from the Short-term Phase IV PREVAIL US Trial in Patients With Primary Hyperlipidemia or Mixed Dyslipidemia 2016 ·Clinical Therapeutics ·(unknown), Seth S. Martin, Parag H. Joshi, Steven R. Jones, Joseph M. Massaro, Ralph B. D’Agostino, Craig A. Sponseller, Peter P. Tóth	18
9	Comparison of the Lipid-Lowering Effects of Pitavastatin 4 mg Versus Pravastatin 40 mg in Adults With Primary Hyperlipidemia or Mixed (Combined) Dyslipidemia: A Phase IV, Prospective, US, Multicenter, Randomized, Double-blind, Superiority Trial 2014 ·Clinical Therapeutics ·Craig A. Sponseller, Roger Morgan, (unknown), Stuart Campbell, Michael H. Davidson	24
10	Factors associated with statin selection among privately insured commercial and Medicare patients 2013 ·Current Medical Research and Opinion ·Zhenxiang Zhao, Jay Bae, Craig A. Sponseller, Yajun Emily Zhu, (unknown), LeRoy LeNarz	1
11	SHORT-TERM AND LONG-TERM EFFECTS OF PITAVASTATIN AND SIMVASTATIN ON FASTING PLASMA GLUCOSE IN PATIENTS WITH PRIMARY HYPERLIPIDEMIA OR MIXED DYSLIPIDEMIA AND ≥2 RISK FACTORS FOR CORONARY HEART DISEASE 2012 ·Journal of the American College of Cardiology ·(unknown), Mats Eriksson, Neil Hounslow, Craig A. Sponseller	4
12	Effects of Steady-State Lopinavir/Ritonavir on the Pharmacokinetics of Pitavastatin in Healthy Adult Volunteers 2012 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Roger Morgan, Stuart Campbell, (unknown), Craig A. Sponseller, Christine Yu, Matthew M. Medlock	24
13	Comparison of the Safety, Tolerability, and Pharmacokinetic Profile of a Single Oral Dose of Pitavastatin 4 mg in Adult Subjects With Severe Renal Impairment Not on Hemodialysis Versus Healthy Adult Subjects 2012 ·Journal of Cardiovascular Pharmacology ·Roger Morgan, Stuart Campbell, Christine Yu, Craig A. Sponseller, (unknown)	21
14	PITAVASTATIN 4 MG PROVIDES SIGNIFICANTLY GREATER REDUCTION IN LDL-C COMPARED TO PRAVASTATIN 40 MG WITH NEUTRAL EFFECTS ON GLUCOSE METABOLISM: PRESPECIFIED SAFETY ANALYSIS FROM THE SHORT-TERM PHASE 4 PREVAIL US TRIAL IN PATIENTS WITH PRIMARY HYPERLIPIDEMIA OR MIXED DYSLIPIDEMIA 2012 ·Journal of the American College of Cardiology ·(unknown), Roger Morgan, Craig A. Sponseller, Michael H. Davidson	6
15	ATORVASTATIN BUT NOT PITAVASTATIN SIGNIFICANTLY INCREASES FASTING PLASMA GLUCOSE IN PATIENTS WITH TYPE 2 DIABETES AND COMBINED DYSLIPIDEMIA 2011 ·Journal of the American College of Cardiology ·(unknown), Janusz Gumprecht, Baojin Zhu, Christine Yu, Neil Hounslow, Craig A. Sponseller	7
16	Interim results of a pilot study demonstrating the early effects of the PPAR-γ ligand rosiglitazone on insulin sensitivity, aminotransferases, hepatic steatosis and body weight in patients with non-alcoholic steatohepatitis 2003 ·Journal of Hepatology ·Brent A. Neuschwander‐Tetri, Elizabeth M. Brunt, Kent R. Wehmeier, Craig A. Sponseller, (unknown), Bruce R. Bacon	100
17	Treatment of hepatitis B and C following liver transplantation 2002 ·Current Gastroenterology Reports ·Craig A. Sponseller, Sanjay Ramrakhiani	2
18	Does the Mayo Clinic end-stage liver disease model (MELD) accurately allocate organs to 2A patients? 2001 ·Gastroenterology ·Craig A. Sponseller, Sanjay Ramrakhiani, Alex S. Befeler	1
19	Clinical improvement in patients with decompensated liver disease caused by hepatitis B after treatment with lamivudine 2000 ·Liver Transplantation ·Craig A. Sponseller, Bruce R. Bacon, Adrian M. Di Bisceglie	26
20	Sensitivity of human glioma and brain cells to natural killer cell lysis 1992 ·Journal of neurosurgery ·René L. Myers, Ronald L. Whisler, Ralph E. Stephens, Craig A. Sponseller, (unknown), Paul M. Spring, Allan J. Yates	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact